Valuation Active Biotech AB

Stocks

Real-time Estimate Cboe Europe 18:33:57 11/11/2026 +03			5-day change	1st Jan Change
3.508 ^SEK	+1.53%		-15.73%	-24.89%

11-05	Active Biotech's operating loss increased in the third quarter, flags capital needs	FW
11-05	Active Biotech AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	275.5	254.8	165.1	115.9	121.3	91.08	-	-
Change	-	-7.51%	-35.2%	-29.8%	4.6%	-24.89%	-	-
Enterprise Value (EV)	223.1	254.8	128.9	88.53	121.3	91.08	91.08	91.08
Change	-	14.2%	-49.4%	-31.34%	36.97%	-24.89%	0%	0%
P/E	-	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-	-	1.55x	0.95x
EV / Revenue	-	-	-	-	-	-	1.55x	0.95x
EV / EBITDA	-0x	-0x	-0x	-0x	-0x	-2.88x	3.41x	1.95x
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-2.74x	3.63x	2.01x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	58.6	96.3
EBITDA ¹	-48.5	-56.4	-44.8	-38.2	-36	-31.6	26.7	46.8
EBIT ¹	-49.8	-57.9	-46.5	-39.8	-37.6	-33.2	25.1	45.2
Net income ¹	-49.8	-58.4	-45.8	-39.4	-37.32	-33.2	25.1	45.2
Net Debt	-52.37	-	-36.2	-27.4	-	-	-	-
Reference price ²	126.400	96.200	45.650	10.880	4.600	3.455	3.455	3.455
Nbr of stocks (in thousands)	2,180	2,649	3,617	10,655	26,361	26,361	-	-
Announcement Date	3/25/22 A	2/9/23 A	2/8/24 A	2/13/25 A	4/1/26 A	-	-	-

¹SEK in Million²

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ACTIVE BIOTECH AB	-	-	-	-	9.2M
WUXI APPTEC CO., LTD.	17.83x	6.86x	13.15x	1.67%	68.32B
ARGENX SE	32.59x	8.71x	28.8x	0.07%	60.26B
LONZA GROUP AG	38.31x	6.82x	20.38x	0.85%	55.86B
BEONE MEDICINES AG	47.19x	6.4x	30.36x	-.--%	48.43B
IQVIA HOLDINGS INC.	35.91x	3.38x	14.61x	-.--%	45.34B
REVOLUTION MEDICINES, INC.	-23.04x	61.61x	-25.45x	-.--%	41.76B
CELLTRION, INC.	34.38x	8.51x	22.17x	0.38%	34.5B
GENMAB A/S	41.76x	8.19x	27.2x	-.--%	33.8B
WUXI BIOLOGICS (CAYMAN) INC.	30.01x	6.36x	16.49x	-.--%	25.96B
Average	28.33x	12.98x	16.41x	0.33%	41B
Weighted average by Cap.	28.12x	12.42x	16.79x	0.43%